UDP-6-glucose Dehydrogenase in Hormonally Responsive Breast Cancers

Overview

Journal bioRxiv

Date 2024 Apr 2

PMID 38562874

Authors

Meghan J Price

Annee D Nguyen

Corinne Haines

Cesar D Baeta

Jovita Byemerwa

Debarati Murkajee

Sandeep Artham

Vardhman Kumar

Catherine Lavau

Suzanne Wardell

Shyni Varghese

C Rory Goodwin

Affiliations

Soon will be listed here.

Abstract

Survival for metastatic breast cancer is low and thus, continued efforts to treat and prevent metastatic progression are critical. Estrogen is shown to promote aggressive phenotypes in multiple cancer models irrespective of estrogen receptor (ER) status. Similarly, UDP-Glucose 6-dehydrogenase (UGDH) a ubiquitously expressed enzyme involved in extracellular matrix precursors, as well as hormone processing increases migratory and invasive properties in cancer models. While the role of UGDH in cellular migration is defined, how it intersects with and impacts hormone signaling pathways associated with tumor progression in metastatic breast cancer has not been explored. Here we demonstrate that UGDH knockdown blunts estrogen-induced tumorigenic phenotypes (migration and colony formation) in ER+ and ER- breast cancer . Knockdown of UGDH also inhibits extravasation of ER- breast cancer , primary tumor growth and animal survival in both ER+ and ER- breast cancer. We also use single cell RNA-sequencing to demonstrate that our findings translate to a human breast cancer clinical specimen. Our findings support the role of estrogen and UGDH in breast cancer progression provide a foundation for future studies to evaluate the role of UGDH in therapeutic resistance to improve outcomes and survival for breast cancer patients.

References

Kumar V, Kingsley D, Perikamana S, Mogha P, Goodwin C, Varghese S . Self-assembled innervated vasculature-on-a-chip to study nociception. Biofabrication. 2023; 15(3). PMC: 10152403. DOI: 10.1088/1758-5090/acc904. View

Friedl A, Jordan V . Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss. Eur J Cancer. 1994; 30A(10):1559-64. DOI: 10.1016/0959-8049(94)00293-e. View

Chen M, Whisler J, Frose J, Yu C, Shin Y, Kamm R . On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics. Nat Protoc. 2017; 12(5):865-880. PMC: 5509465. DOI: 10.1038/nprot.2017.018. View

Oyinlade O, Wei S, Lal B, Laterra J, Zhu H, Goodwin C . Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration. Oncogene. 2018; 37(20):2615-2629. PMC: 5957772. DOI: 10.1038/s41388-018-0138-y. View

Gupta P, Kuperwasser C . Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol. 2006; 102(1-5):71-8. DOI: 10.1016/j.jsbmb.2006.09.025. View

Pang L, Gan C, Xu J, Jia Y, Chai J, Huang R . Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies. Cancers (Basel). 2022; 14(23). PMC: 9738274. DOI: 10.3390/cancers14235727. View

Wang T, Pan Y, Fu C, Chang H . Down-regulation of UDP-glucose dehydrogenase affects glycosaminoglycans synthesis and motility in HCT-8 colorectal carcinoma cells. Exp Cell Res. 2010; 316(17):2893-902. DOI: 10.1016/j.yexcr.2010.07.017. View

Kong X, Wang Q, Li J, Li M, Deng F, Li C . Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance. Eur J Histochem. 2022; 66(2). PMC: 9012142. DOI: 10.4081/ejh.2022.3315. View

Treeck O, Schuler-Toprak S, Ortmann O . Estrogen Actions in Triple-Negative Breast Cancer. Cells. 2020; 9(11). PMC: 7692567. DOI: 10.3390/cells9112358. View

10.

Buijs J, van der Pluijm G . Osteotropic cancers: from primary tumor to bone. Cancer Lett. 2008; 273(2):177-93. DOI: 10.1016/j.canlet.2008.05.044. View

11.

Nguyen A, Haines C, Price M, Dalton T, Baeta C, Hockenberry H . Single-cell RNA sequencing comparison of the human metastatic prostate spine tumor microenvironment. STAR Protoc. 2024; 5(1):102805. PMC: 10867439. DOI: 10.1016/j.xpro.2023.102805. View

12.

Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis A . Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 2012; 279(7):1177-97. DOI: 10.1111/j.1742-4658.2012.08529.x. View

13.

Lev S . Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem Soc Trans. 2020; 48(2):657-665. DOI: 10.1042/BST20191055. View

14.

Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P . UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019; 571(7763):127-131. DOI: 10.1038/s41586-019-1340-y. View

15.

Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi G, Ueno N . Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat. 2012; 136(2):331-45. PMC: 3832208. DOI: 10.1007/s10549-012-2289-9. View

16.

Giese A, Loo M, Tran N, Haskett D, Coons S, Berens M . Dichotomy of astrocytoma migration and proliferation. Int J Cancer. 1996; 67(2):275-82. DOI: 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9. View

17.

Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J . Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci. 2009; 1155:132-40. DOI: 10.1111/j.1749-6632.2008.03685.x. View

18.

Sun J, Hu L, Bok S, Yallowitz A, Cung M, McCormick J . A vertebral skeletal stem cell lineage driving metastasis. Nature. 2023; 621(7979):602-609. PMC: 10829697. DOI: 10.1038/s41586-023-06519-1. View

19.

Lu P, Takai K, Weaver V, Werb Z . Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011; 3(12). PMC: 3225943. DOI: 10.1101/cshperspect.a005058. View

20.

Gyorffy B, Lanczky A, Eklund A, Denkert C, Budczies J, Li Q . An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2009; 123(3):725-31. DOI: 10.1007/s10549-009-0674-9. View